Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 33301227

Optimal Avapritinib Treatment Strategies for Patients with Metastatic or Unresectable Gastrointestinal Stromal Tumors.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Oncologist
Publication date
2021 Apr
First author
Joseph CP

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships

    Authors and identifiers

    1. name
      Joseph CP
      type
      Author
    2. name
      Abaricia SN
      type
      Author
    3. name
      Angelis MA
      type
      Author
    4. name
      Polson K
      type
      Author
    5. name
      Jones RL
      type
      Author
    6. name
      Kang YK
      type
      Author
    7. name
      Riedel RF
      type
      Author
    8. name
      Schöffski P
      type
      Author
    9. name
      Serrano C
      type
      Author
    10. name
      Trent J
      type
      Author
    11. name
      Tetzlaff ED
      type
      Author
    12. name
      Si TD
      type
      Author
    Complete bibliographic record and source provenance
    authors
    1. name
      Joseph CP
      type
      Author
    2. name
      Abaricia SN
      type
      Author
    3. name
      Angelis MA
      type
      Author
    4. name
      Polson K
      type
      Author
    5. name
      Jones RL
      type
      Author
    6. name
      Kang YK
      type
      Author
    7. name
      Riedel RF
      type
      Author
    8. name
      Schöffski P
      type
      Author
    9. name
      Serrano C
      type
      Author
    10. name
      Trent J
      type
      Author
    11. name
      Tetzlaff ED
      type
      Author
    12. name
      Si TD
      type
      Author
    bibliography ids
    1. nci-bib-b1162ee259399a1f86f7d290
    book metadata
    content sha256
    99e176d96df3e3969cbe65523f94863d560a450535b963553d898aec5043b051
    document type
    citation
    dois
    1. 10.1002/onco.13632
    electronic publication date
    display
    2021 Jan 5
    precision
    day
    year
    2021
    evidence scope
    bibliographic_metadata_only
    id
    pubmed:33301227
    immutable id
    pubmed:33301227@99e176d96df3e3969cbe65523f94863d560a450535b963553d898aec5043b051
    journal
    abbreviation
    Oncologist
    issn electronic
    1549-490X
    issn print
    1083-7159
    issue
    4
    name
    The oncologist
    nlm unique id
    9607837
    pages
    e622-e631
    volume
    26
    languages
    1. eng
    notices
    absence is not clearance
    true
    has correction metadata
    false
    has expression of concern metadata
    false
    has retraction in link
    false
    pubmed marks article retracted
    false
    pubmed marks retraction notice
    false
    relationships
      outcomes validated
      false
      pmid
      33301227
      provenance
      batch id
      9bca82d1bba2b27adc79
      provider
      NCBI PubMed ESummary
      record sha256
      ce2980438432adaecdc797fd802d3ef2513ba51e6b29ce9debda9e255300a664
      response sha256
      c8a4853c65a45038af15f5ade3970763bfa121cf5c68bafcc52c3a06860d0211
      retrieved at
      2026-09-09T23:47:56.131551+00:00
      publication date
      display
      2021 Apr
      precision
      month
      year
      2021
      publication types
      1. Clinical Trial, Phase I
      2. Journal Article
      3. Research Support, Non-U.S. Gov't
      record status
      PubMed - indexed for MEDLINE
      schema version
      1.0
      source url
      https://pubmed.ncbi.nlm.nih.gov/33301227/
      title
      Optimal Avapritinib Treatment Strategies for Patients with Metastatic or Unresectable Gastrointestinal Stromal Tumors.

      Preserved source evidence · Not medical advice